5 S&P 500 Stocks Hit 52-Week Lows On Tuesday
A technology giant’s sharp decline anchors a short list of market laggards, raising questions about price versus performance.
A company worth about $367.8 billion does not often hit a 52-week low, and it certainly does not often do so by declining 30.3% in a single month. Yet that is the story with Oracle (ORCL), the largest name on today’s list. While the S&P 500 returned +1.9% over the last month, a small group of its components moved in the opposite direction.
As of Tuesday, just 5 S&P 500 stocks are at their weakest price of the past year. The central question is what to make of such a steep fall in a market that is otherwise climbing. The full list of names follows.
The Complete 52-Week-Low List
- Where The Buying Ran Strongest: 26 S&P 500 Stocks At 52-Week Highs
- Small Cap Stocks At 52-Week Highs: Tuesday’s Full List
- Where The Buying Ran Strongest: 16 Mid Cap Stocks At 52-Week Highs
- S&P 500 Movers | Winners: CRWD, GS, CVNA | Losers: IBM, BIIB, HCA
- Market Movers | Winners: BRKH, NXTC, VEEE | Losers: LESL, MTNB, IBM
- Where The Selling Ran Deepest: 16 Stocks At 52-Week Lows
Here are all 5 names, sorted by market capitalization, with returns over four windows:
| Tickers | Market Cap |
1D % Chg |
1W % Chg |
1M % Chg |
1Y % Chg |
|---|---|---|---|---|---|
| ORCL | $367.8 Bil | -2.7% | -9.3% | -30.3% | -43.9% |
| ISRG | $134.7 Bil | -6.8% | -11.2% | -8.1% | -25.9% |
| BSX | $63.3 Bil | -4.5% | -5.9% | -9.6% | -58.7% |
| LVS | $30.0 Bil | -2.4% | -2.8% | -11.5% | -8.3% |
| CSGP | $11.4 Bil | -3.8% | -7.3% | -15.2% | -67.6% |
Is the business shrinking as fast as the stock price?
The numbers suggest a disconnect. Oracle’s stock has seen a severe one-month slide, but its revenue grew 17.4% over the last twelve months. Another name on the list, Las Vegas Sands (LVS), shows a similar pattern. Its revenue grew 22.7% over the last twelve months, and the company trades at 16.3 times trailing earnings with a free cash flow yield of 7.5%. In these cases, the recent stock performance is not reflective of recent top-line business growth.
A low price is a starting point, not a conclusion.
A 52-week-low list is not inherently a buy list or a sell list. It is a catalog of acute investor pessimism, which may or may not be justified. A stock at its yearly low can signal a business with genuine structural damage, or it can be a fundamentally sound operation that has simply been marked down. The disciplined move is to investigate the business behind the ticker before reacting to the price.
A 52-week-low list tells you where the pain is; it does not tell you which of these declines are worth buying. That second question is what our Buy the Dip screen answers, every day: beaten-down names where the fundamentals still hold up.
A 52 Week Low Is A Stress Test For Concentrated Portfolios
Every stock on this list just showed its holders what a bad year feels like. How much damage any single position could do to your net worth is a question with a precise answer. The Trefis Wealth team computes it for investors professionally, with the same rules-based systematic discipline that runs our High Quality Portfolio. Request a free vulnerability audit of your biggest positions.